达格列净联合胰岛素强化治疗对新诊断 2 型糖尿病患者的效果
摘要
关键词
全文:
PDF参考
[1]魏雪芳,杨煜.达格列净联合胰岛素强化治疗对新诊断 2 型糖尿病患者的效果[J].中外医学研究,2021,19(1):52-54. [2]He J,Dai P,Liu L,et al.The effect of short term intensive insulin therapy on inflammatory cytokines in patients with newly diagnosed type 2 diabetes[J].Journal of diabetes. 2022,12(3):13250-13255. [3]赵小莹,邵海琳,郝兆虎,等.达格列净联合胰岛素短期强化治疗对新诊断 2 型糖尿病患者的效果[J].临床医学,2022,42(4):3-5. [4]戴晓育.达格列净联合胰岛素短期强化治疗对新诊断 2 型糖尿病患者的疗效分析[J].中国实用医药,2022,17(15):46-48. [5]Xiong X,Wei L,Xiao Y,et al.Effects of family history of diabetes on pancreatic β-cell function and diabetic ketoacidosis innewly diagnosed patients with type 2 diabetes:a cross-sectional study in China[J].BMJ Open,2021,11(1):41072-41076. [6]李花英,蔡吓明,陈翔.达格列净联合胰岛素强化治疗对老年 2 型糖尿病胰岛素用量及血糖指标影响[J].糖尿病新世界,2022,21(16):25-27. [7]佟成成.达格列净联合胰岛素治疗 2 型糖尿病的临床观察[J].饮食保健,2021,23(19):70-73. [8]Sia H K,Kor C T,Tu S T,et al.Self-monitoring of blood glucose in association with glycemic control in newly diagnosed non-insulin-treated diabetes patients:a retrospective cohort study[J].Scientific Reports,2021,11(1):81024-81027. [9]林敏.达格列净联合短期胰岛素强化治疗对初治 2 型糖尿病患者代谢指标的影响[J].中华肥胖与代谢病电子杂志,2022,8(1):24-29. [10]Gu M,Wang P,Xiang S,et al.Effects of type 2 diabetes and metformin on salivary microbiota in patients with chronic periodontitis[J].Microbial Pathogenesis,2021,161(55):105277-105280. [11]马靖,孙晓燕,郭春斌.达格列净联合胰岛素泵强化治疗应用于初诊 2 型糖尿病患者疗效观察[J].中国保健营养,2021,31(13):73-74. [12]焦秀敏,刘佳,符静,等.达格列净联合胰岛素泵治疗新诊断 2 型糖尿病的效果及对血糖波动的影响[J].中国医药,2022,12(8):17-20. [13]马靖,孙晓燕,郭春斌.达格列净联合胰岛素泵强化治疗应用于初诊 2 型糖尿病患者疗效观察[J].中国保健营养,2021,31(13):73-74. [14]Ana Cristina García-Ulloa,Lechuga-Fonseca C,Razo-Olvera F M D,et al.Clinician prescription of lipid-lowering drugs and achievement of treatment goals in patients with newly diagnosed type 2 diabetes mellitus[J].BMJ Open Diabetes Research & Care,2021,9(11):1891-1893. [15]黄金惠,黎茂尧.达格列净联合胰岛素强化治疗难治性 2 型糖尿病的疗效探讨[J].糖尿病新世界,2021,24(11):55-58
(13 摘要 Views, 16 PDF Downloads)
Refbacks
- 当前没有refback。